thymoquinone has been researched along with Bile Duct Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdualmjid, RJ; Sergi, CM | 1 |
| Jiang, H; Li, S; Liu, L; Ma, Y; Pan, H; Pan, S; Wang, D; Wang, J; Wu, Y; Xu, D; Zhang, Y; Zhao, B | 1 |
1 review(s) available for thymoquinone and Bile Duct Cancer
| Article | Year |
|---|---|
Mitochondrial Dysfunction and Induction of Apoptosis in Hepatocellular Carcinoma and Cholangiocarcinoma Cell Lines by Thymoquinone.
Topics: Animals; Apoptosis; Benzoquinones; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cell Line, Tumor; Cholangiocarcinoma; Liver Neoplasms; Mitochondria | 2022 |
1 other study(ies) available for thymoquinone and Bile Duct Cancer
| Article | Year |
|---|---|
Thymoquinone induces G2/M arrest, inactivates PI3K/Akt and nuclear factor-κB pathways in human cholangiocarcinomas both in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzoquinones; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cholangiocarcinoma; Down-Regulation; Drug Resistance, Neoplasm; Humans; M Phase Cell Cycle Checkpoints; Mice; Mice, Nude; Neovascularization, Pathologic; NF-kappa B; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Random Allocation; Xenograft Model Antitumor Assays | 2014 |